Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.

Purpose: To determine whether late gadolinium MRI enhancement of colorectal liver metastases (CRCLM) post-chemotherapy is associated with tumour fibrosis and survival post-hepatectomy.Materials and Methods: The institutional review board approved this retrospective cohort study and waived the requir...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 28; no. 8; pp. 3505 - 3513
Autores principales: Cheung, Helen M. C., Karanicolas, Paul J., Hsieh, Eugene, Coburn, Natalie, Maraj, Tishan, Kim, Jin K., Elhakim, Howaida, Haider, Masoom A., Law, Calvin, Milot, Laurent
Formato: Journal Article
Publicado: Springer Nature Aug2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=130553039&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 130553039
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Aug2018
      vid: 28
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        130553039
        130553039
        NLM29476216
        10.1007/s00330-018-5331-4
        NLM29476216
        130553039
      ppf: 3505
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
      aug:
        au:
          Cheung, Helen M. C.
          Karanicolas, Paul J.
          Hsieh, Eugene
          Coburn, Natalie
          Maraj, Tishan
          Kim, Jin K.
          Elhakim, Howaida
          Haider, Masoom A.
          Law, Calvin
          Milot, Laurent
        affil: Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Rm AB 279, Toronto, ON, Canada
      sug:
        subj:
          Liver Neoplasms Surgery
          Image Enhancement Methods
          Magnetic Resonance Imaging Methods
          Colorectal Neoplasms Pathology
          Hepatectomy
          Organometallic Compounds Pharmacokinetics
          Liver Pathology
          Liver
          Liver Surgery
          Reproducibility of Results
          Liver Neoplasms
          Survival Analysis
          Contrast Media Pharmacokinetics
          Liver Neoplasms Drug Therapy
          Retrospective Design
          Cox Proportional Hazards Model
          Aged
          Male
          Female
          Fibrosis
          Aged: 65+ years
          Male
          Female
      ab: Purpose: To determine whether late gadolinium MRI enhancement of colorectal liver metastases (CRCLM) post-chemotherapy is associated with tumour fibrosis and survival post-hepatectomy.Materials and Methods: The institutional review board approved this retrospective cohort study and waived the requirement for informed consent. A cohort of 121 surgical patients who received preoperative MRI after chemotherapy between 2006-2012 was included in this study. Target tumour enhancement (TTE), defined as the mean contrast-to-noise ratio of up to two target lesions on late-phase gadobutrol-enhanced MRI, was determined by two independent raters. The average TTE was correlated with tumour fibrosis on post-hepatectomy specimens using Spearman correlation and with survival post-hepatectomy using Kaplan-Meier and Cox regression. Inter-rater reliability was determined using relative intra-class correlation coefficients.Results: In the surgical cohort (mean age: 63.0 years; male: 58%), TTE was associated with tumour fibrosis (r = 0.43, p < 0.001). Strong TTE was associated with improved survival compared to weak TTE (3-year survival: 88.4% vs. 58.8%, p = 0.003) with a hazard ratio of 0.32 (95% CI: 0.14-0.75, p = 0.008), after taking into account known prognostic variables. Inter-rater reliability was very good with a relative intraclass correlation of 0.84 (95% CI: 0.77-0.89).Conclusion: Late gadolinium MRI enhancement of CRCLM post-chemotherapy is associated with tumour fibrosis and survival.Key Points: • MRI enhancement of colorectal liver metastases is associated with survival post-hepatectomy • MRI enhancement of chemotherapy-treated colorectal liver metastases correlates with tumour fibrosis • Measuring late MRI enhancement using target tumour enhancement is reliable.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N